The invention describes novel pharmaceutically acceptable salt forms of camostat, processes for lyophilisation, taste-masked formulations, nebulised formulations and the use of each of the fore-going in the treatment of respiratory diseases, particularly cystic fibrosis and chronic obstructive pulmonary disease (COPD).
申请公布号
EP2253612(A1)
申请公布日期
2010.11.24
申请号
EP20100161362
申请日期
2006.04.12
申请人
NOVARTIS AG;NOVARTIS PHARMA GMBH;IRM LLC
发明人
DANAHAY, HENRY LUKE;LEGRAND, DARREN MARK;TULLY, DAVID C.;HARRIS, JENNIFER LESLIE;HEUERDING, SILVIA;SINGH, DILRAJ;MAAS, JANET CATHERINE;ROETTELE, JUERGEN;REBER, JEAN-LOUIS;MONNIER, STEPHANIE